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during hematopoiesis (Figure 1) (Liu et al. 2001). ImDCs
and pre-DCs have the following differences: (1) imDCs,
but not pre-DCs, have dendrites or veils; and (2) imDCs
express moderate levels of costimulatory molecules and
induce moderate T cell activation in vitro. By contrast,
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isolated pre-DCs express very low levels of costimula-
tory molecules and do not induce significant naı¨ve T cellDendritic cells (DCs) are professional antigen presenting
activation in culture; (3) imDCs, but not pre-DCs, havecells, which display an extraordinary capacity to stimu-
high mobility in culture, and colonize nonlymphoid tis-late naı¨ve T cells and initiate primary immune responses.
sues in the absence of stimulation; and (4) functionally,This established function of DCs has now offered the
pre-DCs are more directly involved in innate immunityhope to apply DC-based immunotherapy for cancers.
against microbes, as compared to imDCs (detailed later).Recent studies suggest that DCs also play critical roles
Pre-DC1s and pre-DC2s display many different prop-in the induction of peripheral immunological tolerance,
erties (Table 2). While pre-DC1s express the myeloidregulate the types of T cell immune responses, and func-
antigens CD11b, CD11c, CD13, CD14, and CD33 (Liu ettion as effector cells in innate immunity against microbes.
al. 2001), pre-DC2s express mRNA specific for lympho-The diverse functions of DCs in immune regulation depend
cytes such as pre-T, Ig-like 14.1, and Spi-B (Spits eton the diversity of DC subsets and lineages, and on the
al. 2000, Bendriss-Vermare et al. 2001). Pre-DC1 andfunctional plasticity of DCs at the immature stage.
pre-DC2 express different sets of pattern recognitionAntigen-Independent Development and
receptors. Pre-DC1s, but not pre-DC2s, express man-Diversification of Immature DCs and DC
nose receptors. In addition, pre-DC1s, but not pre-Precursors in the Bone Marrow
DC2s, express CD1a, b, c, and d. Pre-DC1s differentiate
Like other cell types within the immune system, imma-
into immature myeloid DCs (im-DC1) in culture with GM-
ture DCs (imDCs) are continuously produced from he-
CSF and IL-4, or after phagocytosis of bacteria. Pre-
matopoietic stem cells within the bone marrow. FLT-3
DC2s differentiate into imDC2s in culture with IL-3, or
ligand, and to a lesser extent GM-CSF, may represent
following an innate immune response to viral stimulation
the key DC growth and differentiation factors in vivo (Table 3). DCs derived from pre-DC1s and pre-DC2s
(Pulendran et al. 2001). CD34 hematopoietic stem cells cultured with GM-CSFIL-4, and IL-3, respectively, dis-
differentiate into common lymphoid progenitors (CLP) play different functional properties after CD40 ligand
and common myeloid progenitors (CMP) in the bone activation (Table 3). DC1s produce large amounts of IL-
marrow (Figure 1). CD34 CMPs appear to differentiate 12 and induce strong T helper type 1 (TH1) and cytotoxic
into CD34CLA and CD34CLA populations, which T lymphocyte (CTL) responses, while DC2s do not pro-
subsequently differentiate into CD11cCD1a and duce large amounts of IL-12, and induce TH2 responses,
CD11cCD1a imDCs, respectively (Strunk et al. 1997). or the generation of IL-10-producing CD8 T suppressor
While CD11cCD1a imDCs migrate into the skin epider- cells (Rissoan et al. 1999, Ito et al. 2001). Unlike IL-3-
mis and become Langerhans cells, CD11cCD1a imDCs and CD40 ligand-induced DC2s, which promote TH2
migrate into the skin dermis and other tissues, and be- responses, viral-induced DC2s promote helper T cells
come interstitial imDCs (Figure 1) (Ito et al., 1999). The to produce both IFN- and IL-10 (Table 3).
CD34 stem cell-derived Langerhans cells and intersti- In mice, splenic DCs were originally separated into
tial imDCs display different phenotypes and functions CD8CD11b and CD8CD11b subpopulations
(Table 1) (Caux et al. 1997). While Langerhans cells ex- (Shortman, 2000). CD8 DCs have the ability to produce
press CD1a, Lag-antigen and E-cadherin, interstitial large amounts of IL-12, induce TH1 responses, and
imDCs express CD2, CD9, CD68, and FactorX111a. In- cross-prime CD8 T cells. By contrast, CD8 DCs do
terstitial imDCs, but not Langerhans cells, have the abil- not have the ability to produce large amounts of IL-12.
ity to take up large amounts of antigens by the mannose They preferentially induce TH2 resp and do not have
receptors and to produce IL-10, which may contribute the ability to cross-prime CD8 T cells (Table 4) (Pulen-
to naı¨ve B cell activation and IgM production in the dran et al. 2001). Recently, the CD8CD11bDC subset
presence of CD40 ligand and IL-2. Because imDCs are was further separated into a CD4 subset and a CD4
present in lymphoid and nonlymphoid tissues in the hu- subset (Shortman 2000). The functional differences be-
man fetus and in newborn rats (Fossum, 1989), their tween these two subsets are currently unknown.
production and diversification from CD34 stem cells in Antigen-Independent Migration of imDCs and Their
the bone marrow appear to be a part of hematopoiesis, Potential Function in Immunological Tolerance
Most newly generated imDCs migrate along the follow-which is pathogen-independent and in a steady state
ing route: bone marrow, blood, nonlymphoid tissues,(Figure 1).
lymphatics, and then draining lymph nodes. The pres-In addition to the two subsets of imDCs, stem cells
ence of imDCs in fetal lymph nodes (Fossum, 1989)also give rise to two types of DC precursors, (pre-DCs),
suggests that some imDCs may migrate into lymphmonocytes (pre-DC1) and plasmacytoid cells (pre-DC2),
nodes under a steady-state physiological condition and
do not undergo maturation. These DCs appear to have
a short life span of 3–4 days (Shortman 2000).1 Correspondence: yong-jun.liu@dnax.org
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Table 1. Subsets of Human DC from CD34 HPC
Langerhans cells Interstitial DCs
Phenotype
CD1a  
CD2  
CD9  
CD68  
Factor XIIIa  
E-cadherin  
Birbeck Granule/  
Lag-antigen
Function
Macropinocytosis  
IL-10-production  
B cell activation / 
CD8 T cell-priming  
and present them to T cells. Third, imDCs do not undergo
maturation into an immunogenic form when they capture
self-antigens under physiological conditions. Indeed, re-
cent studies suggest that imDCs have the capacity to
induce peripheral self-tolerance by promoting naı¨ve
CD4 and CD8 T cells to differentiate into IL-10-pro-
ducing T regulatory/suppressor cells (Jonuleit et al.
2000, Dhodapkar et al. 2001).
Antigen-Dependent Migration and Maturation of imDCs
and Their Remarkable Functional Plasticity
imDCs undergo rapid maturation following microbial in-
Figure 1. DC Development, Diversification, Maturation, and Function fection or transplantation. Pattern recognition recep-
CD34 hematopoietic stem cells differentiate into common myeloid tors, such as Toll like receptors (TLRs), expressed by
progenitor cells (CMP) and common lymphoid progenitor cells immature DCs, allow them to recognize microbial anti-
(CLP). The CMPs differentiate into CD34CLA and CD34CLA
gens and undergo maturation into immunogenic formslate progenitor cells. While CD34CLA cells differentiate into
(Kaisho and Akira 2001). Maturing DCs rapidly lose en-CD11cCD1a Langerhans cell precursors, CD34CLA cells differ-
docytic activity, increase surface expression and stabil-entiate into CD11cCD1a interstitial DC precursors in blood. The
blood CD11cCD1a Langerhans cell precursors migrate into the ity of MHC class I- and class II-peptide complexes,
skin epidermis and become Langerhans cells and the CD11cCD1a upregulate the surface expression of adhesion and co-
cells migrate into the skin dermis and other tissues to become stimulatory molecules (CD40, CD54, CD80, and CD86),
interstitial DCs. The above processes of DC development and diver-
and secrete proinflammatory cytokines such as IL-1,sification are antigen-independent. Without antigen/pathogen stim-
ulation, both Langerhans cells and interstitial DCs may undergo a
steady-state migration into the draining lymph nodes, where they
may play a critical role in immune tolerance. Upon microbial invasion Table 2. Subsets of Human pre-DCs In Vivo
and inflammation, Langerhans cells and interstitial DCs rapidly mi-
Pre-DC1 Pre-DC2/IPCgrate into the draining lymph nodes. They undergo maturation and
initiate primary immune responses. CMP and CLP also give rise to Phenotype
myeloid pre-DC1s and lymphoid pre-DC2s in bone marrow. They Myeloid marker
migrate into the blood and then to the lymphoid tissues. During CD11b  
bacterial infection, pre-DC1s ingest and kill bacteria and then differ- CD11c  
entiate into DCs and initiate adaptive antibacterial immune re- CD13  
sponses. During viral infection, pre-DC2s rapidly produce large CD14  
amounts of type-1 IFN and then differentiate into DCs and initiate CD33  
adaptive antiviral immune responses. Lymphoid marker
Pre-T  
Ig -like 14.1  
imDCs have long been regarded as “the sentinels” of Spi-B  
the immune system, which patrol the body to capture Pattern recognition receptors
Mannose R / invading pathogens. Recent studies suggest that imDCs
CD1a, b, c, d / may also function as “the police” of the immune system,
Other differentially expressed antigenswhich actively maintain tolerance to self-antigens
CD4  
(Steinman et al. 2000). The tolerogenic function of imDCs CD45RA  
is consistent with three interesting features. First, imDCs CD45R0  
can efficiently capture apoptotic cells and present self- IL3R  
GM-CSFR  antigens to T cells (Steinman et al. 2000). Second, imDCs
Functionare continuously produced from the bone marrow and
phagocytosis & kill bacteria  are widely distributed in the body, giving imDCs the
IFN-/ production  
opportunity to constantly sample different self-antigens
Minireview
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Table 3. Subsets of Human DC from pre-DCs
DC1 DC2 DC2
(GM-CSFIL-4, CD40L) (IL-3, CD40L) (Virus)
Phenotype
CD11b, 11c   ?
CD13, CD33   ?
CD1a, b, c, d   ?
Function
IL-12   
IFN-/   
TH1  (IFN-) /  (IFN-, IL-10)
TH2   
CTL   ?
IL-10 CD8 T suppresors   ?
IL-6, IL-12, IL-18, and IL-23. Maturing DCs rapidly ex- IL-12 and prime for TH1 responses. By contrast, antiin-
flammatory molecules such as IL-10, TGF-, PGE-2, andpress the chemokine receptor CCR7, which drives their
migration into the lymphatics through the CCR7 ligand corticosteroids, all inhibit imDC maturation and IL-12 pro-
duction, and induce TH2 or regulatory T cell responses.6Ckine, and then to draining lymph nodes through an-
other CCR7 ligand, MIP-3. The arriving mature DCs Blood DC Precursors Directly Participate in
Antimicrobial Innate Immune Responses and Undergoscreen for passing antigen-specific naı¨ve T cells, and
induce primary T cell-mediated immune responses in Antigen-Dependent Differentiation into DCs
In contrast to imDCs, which have evolved to process andthe T cell areas of the draining lymph nodes (Sallusto
and Lanzavecchia, 2000). present antigen to T cells, pre-DCs may have originally
evolved to serve as effector cells in antimicrobial innateFollowing allogeneic transplantation, several factors
may contribute to the maturation of donor or host DCs, immunity. Monocytes (pre-DC1) ingest and kill various
bacteria and fungi. Pre-DC2s represent the key effectorwhich are responsible for the initiation of graft rejection
and graft versus host disease: (1) the release of proin- cells in the early antiviral innate immune response by
producing large amounts of IFN-/ upon viral infectionflammatory factors such as cytokines and heat shock
proteins by injured tissues; (2) microbial infection before (Liu et al. 2001). Thus, pre-DC2s are sometimes referred
to as interferon producing cells (IPC). Unlike other ef-and after transplantation; and (3) the degree of MHC mis-
match, which will determine the strength of T cell receptor- fector cells in the innate immune system (such as neutro-
phils, eosinophils, and basophils), which die after per-mediated T cell activation. Additionally, activated alloge-
neic T cells may express CD40 ligand and RANK ligand, forming their functions, pre-DC1s and pre-DC2 s all have
the potential to differentiate into DCs (Liu et al. 2001).key factors for imDC activation and survival.
Mature DCs not only have the capacity to prime naı¨ve The differentiation of pre-DC2 into DC2 during viral in-
fection occurs spontaneously in the absence of exoge-T cells, but they also induce different types of T cell
immune responses depending on the type of original nous cytokines. This differentiation is mediated by type
1 IFNs, which maintain cell survival, and by TNF-, whichmaturation signal. There are two groups of signals that
stimulate imDCs to induce TH1 versus TH2 differentia- induces DC differentiation in an autocrine fashion. Inter-
estingly, while IL-3-induced DC2s promote TH2 differen-tion (Kalinski et al., 1999). Molecules derived from patho-
tiation, virus-induced DC2s promote naı¨ve CD4 T cellsgens, such as lipopolysaccharide, bacterial CpG DNA and
to produce large amounts of IFN- and IL-10. IFN-double-stranded viral RNA, as well as T cell signals such
production by CD4 T cells is dependent on IFN-/as CD40 ligand and IFN-, all promote imDCs to produce
produced by virus-induced DC2s and is IL-12-indepen-
dent. This suggests that both imDCs, as well as pre-DCs,
Table 4. Subsets of mouse DCs have functional plasticity in regulating T cell responses,
depending on the type of differentiation signal.CD8CD4 CD8CD4 CD8CD4
Therefore, the two types of DC precursors, pre-DC1s
Phenotype (monocytes) and pre-DC2s (plasmacytoid cells), func-
CD8   
tion in both innate and adaptive immunity and provideCD11b   
the physical link between the two arms of immunity.CD11c   
CD4    The Lymphoid DC Lineage: Confusions and Facts
B220    The existence of a lymphoid DC lineage was suggested
Ly6    by the finding that DCs can be derived from the earliest
DEC205  /  T cell precursors within the thymus (Shortman, 2000). The
Function
B lymphocyte-related DC lineage was later proposed fol-IL-12   
lowing the demonstration that mouse CD19 pro-B cellsIFN-   
have the potential to differentiate into DCs in cultureIFN-   
TH1  / / (Bjorck and Kincade, 1998). Interestingly, thymic DCs ex-
TH2    press CD8. This observation led to the discovery of CD8
Cross-priming of    and CD8 splenic DC subsets in mice, and the classifica-
CD8 T cells
tion of CD8 lymphoid DCs and CD8 myeloid DCs. This
Cell
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classification became even more attractive following the myeloid pre-DC1s and lymphoid pre-DC2s express dif-
discovery that CD8 and CD8 DC subsets differ in their ferent sets of pattern recognition receptors, and re-
ability to produce IL-12, and induce TH1 versus TH2 spond to different microbial products, suggests that
responses, respectively (Pulendran et al., 2001). these lineages have evolved to preferentially recognize
However, new studies suggest that CD8 is not a different antigens and may activate different, but appro-
lymphoid marker for peripheral DCs. This is because: priate, T cell responses. It will be important to determine
(1) the thymus is not the origin of splenic CD8 DCs, (2) how different pattern recognition receptors instruct DCs
purified myeloid progenitors can give rise to CD8 DCs to initiate appropriate innate and adaptive immune re-
in mice upon adoptive transfer (Traver et al., 2000), and sponses. The ability of DCs to induce appropriate im-
(3) myeloid DCs can be induced to express CD8 in vitro mune response to a particular pathogen may ultimately
by activation (Brasel et al., 2000). Although CD8 cannot be determined by the lineage origin of DCs and their
be used as a lymphoid DC marker for peripheral DCs, innate response to that particular pathogen.
the evidence for a CD8 lymphoid DC lineage within the
Selected Readingthymus is substantial, and CD8 is a valuable marker for
the separation of two functionally different DC subsets.
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